Affinity and kinetic modulation of polyamide-DNA interactions by N-modification of the heterocycles

• Published in: Biopolymers Vol. 99; no. 8; pp. 497 - 507
• Main Authors: Ramos, Joseph P., Babu, Balaji, Chavda, Sameer, Liu, Yang, Plaunt, Adam, Ferguson, Amanda, Savagian, Mia, Lee, Megan, Tzou, Samuel, Lin, Shicai, Kiakos, Konstantinos, Wang, Shuo, Lee, Moses, Hartley, John A., Wilson, W. David
• Format: Journal Article
• Language: English
• Published: United States Blackwell Publishing Ltd 01-08-2013
• Subjects: ACGCGT; Base Sequence; binding affinity; cell-cycle box; Circular Dichroism; diamino; dicationic; DNA; DNA - chemistry; gene control; imidazole; kinetics; MCB; minor groove binder; Mlu1; Nylons; polyamides; pyrrole; sequence selectivity; Surface Plasmon Resonance
• ISSN: 0006-3525; 1097-0282
• DOI: 10.1002/bip.22205

Synthetic N‐methyl imidazole and N‐pyrrole containing polyamides (PAs) that can form “stacked” dimers can be programmed to target and bind to specific DNA sequences and control gene expression. To accomplish this goal, the development of PAs with lower molecular mass which allows for the molecules to rapidly penetrate cells and localize in the nucleus, along with increased water solubility, while maintaining DNA binding sequence specificity and high binding affinity is key. To meet these challenges, six novel f‐ImPy*Im PA derivatives that contain different orthogonally positioned moieties were designed to target 5′‐ACGCGT‐3′. The synthesis and biophysical characterization of six f‐ImPy*Im were determined by CD, ΔTM, DNase I footprinting, SPR, and ITC studies, and were compared with those of their parent compound, f‐ImPyIm. The results gave evidence for the minor groove binding and selectivity of PAs 1 and 6 for the cognate sequence 5′‐ACGCGT‐3′, and with strong affinity, Keq = 2.8 × 108 M−1 and Keq = 6.2 × 107 M−1, respectively. The six novel PAs presented in this study demonstrated increased water solubility, while maintaining low molecular mass, sequence specificity, and binding affinity, addressing key issues in therapeutic development. © 2013 Wiley Periodicals, Inc. Biopolymers 99: 497–507, 2013.